Back to top

cannabis: Archive

Zacks Equity Research

GrowGeneration (GRWG) Buys Stores in Alaska to Boost Portfolio

GrowGeneration (GRWG) acquires two stores in Alaska, increasing the number of states it operates in to 18.

AUNegative Net Change GFINegative Net Change AGINegative Net Change GRWGNegative Net Change

Zacks Equity Research

GrowGeneration (GRWG) Enters Mushroom Industry With GrowLife Deal

GrowGeneration (GRWG) forms an alliance with Bridgetown Mushrooms to sell Bridgetown's mycology products.

GFINegative Net Change AGINegative Net Change PHOTNo Net Change GRWGNegative Net Change

Zacks Equity Research

Innovative Industrial's (IIPR) Q1 Adjusted FFO Beats Estimates

With the cannabis industry gaining prominence, Innovative Industrial's (IIPR) investment in such properties aids its Q1 performance, though high expenses act as a spoilsport.

STAGNegative Net Change IIPRNegative Net Change VICIPositive Net Change

Zacks Equity Research

Factors to Impact Innovative Industrial's (IIPR) Q1 Earnings

With the cannabis industry gaining prominence, Innovative Industrial's (IIPR) investment in such properties is likely to have aided its Q1 performance, though high expenses might have played a spoilsport.

AHHNo Net Change IIPRNegative Net Change

Bryan Hayes

Pot Stocks Surge on SAFE Banking Act Reintroduction

Lawmakers are attempting to make a final push toward delivering financial services for the cannabis industry.

CGCNegative Net Change MSOSPositive Net Change GTBIFPositive Net Change

Bryan Hayes

Is Tilray Brands (TLRY) A Buy Ahead of Fiscal Q3 Earnings Announcement?

Industry headwinds still present a major challenge.

TLRYPositive Net Change

Zacks Equity Research

GrowGeneration (GRWG) Q4 Earnings Miss, Revenues Down Y/Y

GrowGeneration (GRWG) reports lower revenues and a loss per share of 25 cents for the fourth quarter of 2022 due to the ongoing weakness in the cannabis industry and efforts to lower its inventory.

STLDNegative Net Change NUEPositive Net Change GRWGNegative Net Change

Zacks Equity Research

Jazz's (JAZZ) Q4 Earnings Miss Estimates, New Drugs Drive Sales

Jazz (JAZZ) reports dismal fourth-quarter results as earnings and sales miss expectations. Sleep disorder drug Xywav become the company's largest product by net sales during the quarter.

JAZZNegative Net Change AMRNPositive Net Change AXSMNegative Net Change ALLONegative Net Change

Zacks Equity Research

Factors to Impact Innovative Industrial's (IIPR) Q4 Earnings

With the cannabis industry gaining prominence, Innovative Industrial's (IIPR) investment in such properties is likely to have aided its Q4 performance, though high expenses might have played a spoilsport.

PSAPositive Net Change EXRNegative Net Change IIPRNegative Net Change PSTLPositive Net Change

Andrew Rocco

Wednesday Recap: Minty Fresh Breadth

Breadth is an important measure used by investors to determine how strong or weak a market index is beneath the surface. Tuesday, the market flashed very strong breadth - an indication that bulls may be ready to take back the baton.

AAPLNegative Net Change MSFTPositive Net Change SINegative Net Change TSLAPositive Net Change BABAPositive Net Change CGCNegative Net Change